Novan, Inc. (NASDAQ:NOVN) went up by 2.75% from its latest closing price when compared to the 1-year high value of $3.72 and move down -463.64%, while NOVN stocks collected -1.42% of loss with the last five trading sessions. Press Release reported on 01/02/20 that Novan Reports Top-Line Efficacy Results from Phase 3 Trials of SB206 for Molluscum Contagiosum
Novan, Inc. (NASDAQ:NOVN) Worth an Investment?
Novan, Inc. (NASDAQ: NOVN) The 36 Months beta value for NOVN stocks is at 1.92, while of the analysts out of 0 who provided ratings for Novan, Inc. stocks as a “buy” while as overweight, rated it as hold and as sell. The average price we get from analysts is $1.00 which is $0.34 above current price. NOVN currently has a short float of 1.12% and public float of 16.92 M with average trading volume of 423.65K shares.
NOVN Market Performance
NOVN stocks went down by -1.42% for the week, with the monthly drop of -80.60% and a quarterly performance of -72.66%, while its annual performance rate touched -50.99%. The simple moving average for the period of the last 20 days is -44.88% for NOVN stocks with the simple moving average of -69.39% for the last 200 days.
Analysts’ Opinion on Novan, Inc. (NASDAQ:NOVN)
Many brokerage firms have already submitted their reports for NOVN stocks, with Piper Jaffray repeating the rating for NOVN shares by setting it to “Neutral”. The predicted price for NOVN socks in the upcoming period according to Piper Jaffray is $24 based on the research report published on January 6, 2020.
NOVN Stocks -63.84% Far from 50 Day Moving Average
After a stumble in the market that brought NOVN to its low price for the period of the last 52 weeks, Novan, Inc. was unable to take a rebound, for now settling with -82.21% of loss for the given period.
The stock volatility was left at 8.78%, however, within the period of a single month, the volatility rate increased by 8.17%, while the shares sank at the distance of -79.76% for the moving average in the last 20 days. In oppose to the moving average for the last 50 days, trading by -69.65% lower at the present time.
In the course of the last 5 trading sessions, NOVN went down by -1.42%, which changed the moving average for the period of 200 days to the total of -26.31% of losses for the stock in comparison to the 20-day moving average settled at $1.07. In addition, Novan, Inc. saw -79.06% in overturn over the period of a single year with a tendency to cut further losses.
NOVN Stock Insider Trading
Reports are indicating that there were more than several insider trading activities at Novan, Inc. (NOVN), starting from Malin Life Sciences Holdings L, who sold 6,287 shares at the price of $2.75 back on Jul 02. After this action, Rushing now owns 2,598,485 shares of Novan, Inc., valued at $17,289 with the latest closing price.
Malin Life Sciences Holdings L, the 10% Owner of Novan, Inc., sold 913 shares at the value of $2.74 during a trade that took place back on Jul 01, which means that Malin Life Sciences Holdings L is holding 2,604,772 shares at the value of $2,502 based on the most recent closing price.
NOVN Stock Fundamentals
The current profitability levels are settled at -471.19 for the present operating margin. The net margin for Novan, Inc. stands at -211.53. Total capital return value is set at -296.76, while invested capital returns managed to touch -133.38. Equity return holds the value 233.90%, with -79.50% for asset returns.
Based on Novan, Inc. (NOVN), the company’s capital structure generated 154.27 points for debt to equity in total, while total debt to capital is set at the value of 60.67. Total debt to assets is settled at the value of 30.42 with long-term debt to equity ratio rests at -26.96 and long-term debt to capital is 154.06.
The value for Enterprise to Sales is 2.94 with debt to enterprise value settled at 0.38. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.03.